Utilisation disease-modifying anti-rheumatic drugs (DMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study

First published 24/01/2020

Last updated 24/01/2020

EU PAS number:

EUPAS33253

Study

Ongoing

Documents

Study protocol

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols_EUPAS33253

English (207.1 KB - PDF)View document

Secondary tabs